Shares of Axon Enterprise (NASDAQ: AXON) are consolidating on Wednesday following a strong uptrend. The stock is approaching the $637 level, which technical analysis identifies as a key resistance point where the rally may pause or end.

Price Action at Resistance

The $637 level previously served as a top in January. Investors who purchased shares at that peak faced losses as the stock trended lower. Many of these holders retained their positions with the intention of exiting at breakeven if prices recovered.

When Axon shares rallied back to $637 in early July, these investors placed sell orders to exit at their original purchase price. The volume of these orders created renewed resistance at the level. A similar dynamic is currently occurring as investors who bought in early July sell at their entry price.

Market Mechanics

Stocks often sell off after reaching resistance levels. This pattern occurred the last two times Axon reached $637. The mechanism involves anxious sellers reducing their offer prices to avoid further losses, potentially triggering a broader downturn as other sellers follow suit.

Axon Enterprise Inc (NASDAQ: AXON) reported second-quarter revenue of $904.39 million on Wednesday, exceeding analyst estimates of $876.46 million and marking a 35% year-over-year increase. Despite the strong financial performance and an upward revision to full-year guidance, shares fell 6.32% in after-hours trading to $570.95, reflecting investor caution or profit-taking following the earnings release.

The company’s growth was broad-based across its core segments. Software and Services revenue rose 36% year-over-year to $398 million, while Connected Devices revenue grew 35% to $507 million. Management attributed the surge to sustained demand from both new and existing customers. Annual Recurring Revenue (ARR) also expanded significantly, increasing 39% year-over-year to $1.6 billion, primarily fueled by adoption of premium software offerings.

Financial Performance and Guidance

Axon delivered adjusted earnings per share of $1.88 for the quarter, beating consensus estimates of $1.85 per share. The company ended the period with a solid liquidity position, holding $685 million in cash, cash equivalents, and short-term investments as of June 30.

Looking ahead, Axon raised its full-year 2026 revenue guidance from a previous range of $3.61 billion to $3.67 billion to a new range of $3.67 billion to $3.73 billion. This update surpassed analyst expectations of $3.66 billion, signaling management’s confidence in continued momentum through the remainder of the fiscal year.

What the Numbers Show

The divergence between the stock’s negative price action and the positive earnings surprise warrants attention. While the top-line growth of 35% and the beat on both revenue and EPS metrics are objectively strong, the market’s reaction suggests that investors may have priced in higher expectations or are concerned about valuation levels relative to future growth rates. The significant rise in ARR to $1.6 billion indicates a healthy recurring revenue base, which typically supports higher valuation multiples, yet the immediate sell-off implies a potential reassessment of risk or near-term outlook by institutional holders.

The strength in the Software and Services segment, growing faster than hardware, underscores Axon’s successful transition toward a recurring-revenue model. This structural shift reduces dependency on one-off device sales and provides greater visibility into future cash flows, a key factor likely supporting the raised full-year guidance.